A. Lecesne

37 papers receiving 2.2k citations

A. Lecesne's Hit Papers

Mechanisms of Resistance to Antibody-Drug Conjugates 2023 · 95 citations
950+7+14Years since publication4008001.2k

Peers

A. Lecesne
Comparison fields: 5 of 79
  • Gastroenterology 1.1k
  • Pulmonary and Respiratory Medicine 988
  • Oncology 479
  • Hematology 193
  • Rheumatology 211
Replace Antoine Adenis with:
Antoine Adenis France
Margherita Nannini Italy
Satvinder Mudan United Kingdom
P. Berthaud France
B. Bui France
J. Buesa Spain
Heung Moon Chang South Korea
Riccardo Valli Italy
Javier Martínez‐Trufero Spain
Jeffrey D. Wayne United States
A. Lecesne relative to Antoine Adenis France Antoine Adenis's profile →
Citations per field
00.5×6.5×
Antoine Adenis · 1×
Citations per year

Countries citing papers authored by A. Lecesne

Since Specialization
Citations

This map shows the geographic impact of A. Lecesne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lecesne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lecesne more than expected).

Fields of papers citing papers by A. Lecesne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lecesne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lecesne. The network helps show where A. Lecesne may publish in the future.

Co-authors

The 25 scholars most cited alongside A. Lecesne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Lecesne Line = papers co-authored together A. Lecesne links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial
Hit paper breakdown →
20041344
2 2010143
3 2008127
4
Mechanisms of Resistance to Antibody-Drug Conjugates
Hit paper breakdown →
202395
5 201676
6 201360
7 199954
8 200153
9 200039
10 201736
11 201028
12
[Primary cutaneous leiomyosarcoma: 32 cases].
199923
13 201822
14 202017
15
Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
199516
16 201210
17 20099
18 20099
19 20198
20 20078

About A. Lecesne

A. Lecesne is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology, Pathology and Forensic Medicine, Oncology and Hematology, having authored 40 papers that have together received 2.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (18 papers), Gastrointestinal Tumor Research and Treatment (11 papers), Lymphoma Diagnosis and Treatment (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Bone Tumor Diagnosis and Treatments (4 papers), Oral and Maxillofacial Pathology (3 papers), Platelet Disorders and Treatments (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Gastroenterology (1.1k citations), Pulmonary and Respiratory Medicine (988 citations), Oncology (479 citations), Hematology (193 citations) and Rheumatology (211 citations). A. Lecesne has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Jean‐Yves Blay, Paolo G. Casali, Ian Judson, Rossella Bertulli, M. van Glabbeke, Jaap Verweij, A. van Oosterom, Peter Reichardt, Pancras C.W. Hogendoorn and Rolf D. Issels. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, PLoS ONE, British Journal of Cancer and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact